A startup incubated in the Indian Institute of Science (IISc), Bengaluru, is developing a Covid-19 vaccine that can be stored at 37 degrees Celsius, a development that could be a game-changer for India which lacks sufficient cold chain facilities. “.
“All (Covid) vaccine candidates in clinical trials currently require refrigerated temperatures of at least four degrees. Ours would not, in principle,” biophysicist Raghavan Varadarajan, who heads the startup Mynvax, told DH.